CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

Clinical trial NCT05558124 · RECRUITING

Trial details

NCT number: NCT05558124
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2023-02-16
Primary completion: 2027-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.